Effect of Choline Forms and Gut Microbiota Composition on Trimethylamine-N-Oxide Response in Healthy Men

Clara E. Cho,Niklas D. J. Aardema,Madison L. Bunnell,Deanna P. Larson,Sheryl S. Aguilar,Janet R. Bergeson,Olga V. Malysheva,Marie A. Caudill,Michael Lefevre
DOI: https://doi.org/10.3390/nu12082220
IF: 5.9
2020-07-25
Nutrients
Abstract:Background: Trimethylamine-N-oxide (TMAO), a choline-derived gut microbiota-dependent metabolite, is a newly recognized risk marker for cardiovascular disease. We sought to determine: (1) TMAO response to meals containing free versus lipid-soluble choline and (2) effects of gut microbiome on TMAO response. Methods: In a randomized, controlled, double-blinded, crossover study, healthy men (n = 37) were provided meals containing 600 mg choline either as choline bitartrate or phosphatidylcholine, or no choline control. Results: Choline bitartrate yielded three-times greater plasma TMAO AUC (p = 0.01) and 2.5-times greater urinary TMAO change from baseline (p = 0.01) compared to no choline and phosphatidylcholine. Gut microbiota composition differed (permutational multivariate analysis of variance, PERMANOVA; p = 0.01) between high-TMAO producers (with ≥40% increase in urinary TMAO response to choline bitartrate) and low-TMAO producers (with <40% increase in TMAO response). High-TMAO producers had more abundant lineages of Clostridium from Ruminococcaceae and Lachnospiraceae compared to low-TMAO producers (analysis of composition of microbiomes, ANCOM; p < 0.05). Conclusion: Given that phosphatidylcholine is the major form of choline in food, the absence of TMAO elevation with phosphatidylcholine counters arguments that phosphatidylcholine should be avoided due to TMAO-producing characteristics. Further, development of individualized dietary recommendations based on the gut microbiome may be effective in reducing disease risk
nutrition & dietetics
What problem does this paper attempt to address?
The problems that this paper attempts to solve mainly focus on two aspects: 1. **The influence of different forms of choline on the trimethylamine - N - oxide (TMAO) reaction**: Researchers hope to determine whether there are differences in the effects of meals containing free choline and fat - soluble choline on the TMAO levels in healthy men. Specifically, they compared the effects of choline bitartrate (a form of free choline) and phosphatidylcholine (a form of fat - soluble choline) on TMAO levels. 2. **The influence of gut microbiome composition on the TMAO reaction**: Researchers also explored whether differences in the gut microbiome between individuals would affect the production of TMAO. In particular, they hope to reveal whether these differences can explain the different TMAO reactions by analyzing the gut microbiome compositions of high - TMAO producers and low - TMAO producers. ### Research background - **The generation pathway of TMAO**: TMAO is a metabolite produced by gut microbes, and its precursor substance is choline. Choline is converted into trimethylamine (TMA) by specific microbes in the gut, and then TMA is oxidized into TMAO by flavin - containing monooxygenase 3 (FMO3) in the liver. - **The relationship between TMAO and cardiovascular diseases**: In recent years, TMAO has been regarded as a new risk marker for cardiovascular diseases. Therefore, understanding how different forms of choline affect the generation of TMAO is of great significance for evaluating the impact of diet on cardiovascular health. ### Research methods - **Experimental design**: This is a randomized, controlled, double - blind, cross - over designed study. 37 healthy male participants received three kinds of meals respectively: a meal containing 600 mg of choline bitartrate, a meal containing 600 mg of phosphatidylcholine, and a control meal without choline. - **Data collection**: Researchers collected blood and urine samples from participants before and after the meals and measured TMAO and choline. In addition, fecal samples of participants were also collected for analyzing the composition of the gut microbiome. ### Main findings - **The influence of the form of choline**: The increase in plasma TMAO concentration caused by choline bitartrate was significantly higher than that of phosphatidylcholine and the choline - free control group. Specifically, the area under the plasma TMAO curve (AUC) in the choline bitartrate group was three times that of the other two groups, and the change in TMAO in urine was also significantly higher. - **The influence of the gut microbiome**: There were significant differences in the gut microbiome compositions between high - TMAO producers and low - TMAO producers. In high - TMAO producers, Clostridium bacteria in the Ruminococcaceae and Lachnospiraceae families were more abundant. ### Conclusions - **The safety of phosphatidylcholine**: Although choline bitartrate significantly increased the TMAO level, phosphatidylcholine did not cause a significant increase in TMAO. This result indicates that the phosphatidylcholine - form of choline, which mainly exists in food, will not significantly increase the TMAO risk as free choline does. - **Personalized diet recommendations**: Based on the differences in individual gut microbiomes, it may be possible to effectively reduce disease risks through personalized diet recommendations in the future. Through these studies, the author provides important scientific bases for understanding the influence of different forms of choline on TMAO generation and the role of the gut microbiome in it.